Parker Hannifin Corp. (0KFZ)
London Exchange · UK · prices in USD · close of 19 Oct 2026
Key indicators
| Last close | USD 971.08 |
|---|---|
| 52-week range | 696.23 – 1,096.66 |
| Return, 1 month / 3 months | +4.7% / +1.8% |
| Return, 1 year / 3 years | +32.4% / +161.5% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 52 |
| Volatility (1 year) | 26.6% |
| Worst drawdown (1 year) | -19.0% |
| Average daily value traded | 1.12M USD |
| Dividend yield | 0.8% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Parker Hannifin Corp. is an industrial technology company based in the United States that makes motion and control products. Its range includes hydraulic and pneumatic components, electromechanical systems, seals, filters and fluid connectors. Customers come from aerospace, industrial equipment, automotive, energy and other manufacturing markets, and the company supplies both original equipment makers and maintenance operations. It also provides related engineering services and systems for controlling motion in machinery and vehicles.
On this site Parker Hannifin Corp. appears as a stock on the London Exchange (UK), code 0KFZ, with prices in US dollars (USD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Parker Hannifin Corp. (0KFZ) trades on the London Exchange in UK. It last closed at USD 971.08 on 19 October 2026.
Its price-based Market X-Ray is 64 out of 100 (a fair price profile), ranking 1,019 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 32.4% and over the last three months it rose 1.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 62 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 2.7% | ||
| From 52-week high | -9.7% | ||
| Momentum | 62 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 1.8% | ||
| 6-month return | 1.3% | ||
| 12-month return, skipping the last month | 26.4% | ||
| Stability (higher is calmer) | 73 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 26.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -19.0% | ||
| Liquidity | 54 · Fair | Moderate trading activity. | |
| Average daily value traded | 1.12M USD | ||
| Zero-volume days | 0.0% | ||
| Income | 64 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 0.8% | ||
| Years with dividends | 6 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +1.3% |
|---|---|
| 1 month | +4.7% |
| 3 months | +1.8% |
| 6 months | +1.3% |
| 1 year | +32.4% |
| 3 years | +161.5% |
| 5 years | – |
Signals
| 50-day / 200-day average | 984.24 / 945.88 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 30.50 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 28 Aug 2026 | USD 2.0000 |
| 7 May 2026 | USD 2.0000 |
| 5 Feb 2026 | USD 1.8000 |
| 6 Nov 2025 | USD 1.8000 |
| 1 Sep 2025 | USD 1.8000 |
| 8 May 2025 | USD 1.8000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.